Menu

NIH Plans to Enroll 1 Million People for Health Database

The agency says it has taken various steps to ensure the privacy of participants’ data. 

May 3, 2018
Catherine Offord

ISTOCK, PEOPLEIMAGESThe National Institutes of Health (NIH) is planning to enroll 1 million people across the U.S. for a database of genetics, lifestyles, and environmental conditions relating to health. The agency’s “All of Us” program, which will open for volunteer signup on Sunday (May 6), will provide an important tool in the development of treatment and prevention strategies for various diseases, health officials say.

All of Us is an ambitious project that has the potential to revolutionize how we study disease and medicine,” Health and Human Services Secretary Alex Azar says in a statement. “We look forward to working with people of all backgrounds to take this major step forward for our nation’s health.”

The project has secured $1.45 billion in funding for the next decade, and has already enrolled 25,000 participants as part of a pilot run last year. People will first share electronic health records, blood samples, and information about their lifestyles. Later in the year, researchers will start administering tests for particular genetic variants that may be related to disease risk.

See “Estonia Offers Free Genetic Testing to Residents

Now that enrollment is going public, the agency is keen to assuage concerns about the security of the data being collected. “This is something we thought about,” NIH director Francis Collins says in an live-streamed interview with The Washington Post. “We knew this was going to be an issue in getting people comfortable.”

While no database is 100 percent secure, the data will be carefully protected, the project’s director, Eric Dishman, explains. The agency has invited hackers to try to breach the database, he adds, as a way to better develop privacy measures. And, according to Collins and Dishman, the information would be inaccessible to law enforcement, even with search warrants and subpoenas, the Post reports.

See “Genealogy Website Helped Crack Golden State Killer Case

However, lawyer Tiffany Li of Yale Law School expresses skepticism that the data could be shielded from access by law enforcement in all cases. “I would argue that there probably is some way to access the data,” she tells the Post.

If the project succeeds, the database will be the “largest, most diverse resource of its kind,” and will help doctors move toward a patient-specific approach to medical treatment, according to the NIH statement. It’s “a national adventure that is going to transform medical care,” Collins says in the interview. “One-size-fits-all is far from an optimal strategy.”

See “Learning from Iceland’s Model for Genetic Research

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.